Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation

NCT: NCT05368350 · ACTIVE_NOT_RECRUITING

NCT IDNCT05368350
StatusACTIVE_NOT_RECRUITING
Start Date2022-06-01
Completion2027-04-16

Brief Summary

The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area and left inferior frontal gyrus) thought to aid in memory will improve speech and language difficulties in patients with primary progressive aphasia (PPA) and progressive apraxia of speech (PAOS). The primary outcome measures are neuropsychological assessments of speech and language functions, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures.

Frequently Asked Questions

What is Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation?

Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation is a clinical trial registered under NCT05368350. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05368350?

The current status of NCT05368350 (Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation) is: ACTIVE_NOT_RECRUITING.

When did Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation start?

Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation started on 2022-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.